AGP Executive Report

Emergency Care: Fewer than 5% of cardiac-arrest patients in a Malaysian study survived to hospital admission; the median ambulance wait was 17 minutes. Patient Safety: The family of an Arizona toddler found alive in a hospital morgue nearly five hours after being declared dead plans legal action. Infectious Disease: WHO says Nigeria has no active Ebola cases after the infected patient and her husband were evacuated to Switzerland; authorities continue monitoring contacts. Hospital Disruptions: A cybersecurity incident forced University of New Mexico hospitals to divert ambulances and cancel appointments and classes. Cancer Research: A Phase 3 trial found an investigational drug reduced the risk of death by 32% for some patients with advanced or recurrent endometrial cancer. Medicare: Free counseling is available in Central Florida as beneficiaries prepare for 2027 coverage changes.

Hospital Capacity: Northern Samar Provincial Hospital reported 363 patients against its authorized 150-bed capacity and suspended further admissions, urging patients who don’t need specialized care to seek help elsewhere. Ebola Response: WHO says Nigeria has no active Ebola cases after the infected patient and her husband were evacuated to Switzerland; Nigerian authorities will continue monitoring 52 contacts. Surgical Care: A trial across 39 hospitals in China found that adding dobutamine to norepinephrine during septic-shock surgery reduced patients’ risk of acute kidney injury. Cancer Equity: A UK study of more than 86,000 patients found Black people were less likely to have breast cancer detected through routine screening and more likely to be diagnosed in an emergency; patients with learning disabilities also faced longer waits for diagnosis and treatment. Maternal and Child Health: Qatar designated four more health centers as Baby-Friendly, bringing its total to nine facilities supporting breastfeeding and maternal care.

Cancer Care: A global Phase III trial found that adding HUTCHMED’s targeted drug savolitinib to osimertinib cut the risk of progression or death by 45% for some lung cancer patients whose disease worsened on treatment. Healthcare Workforce: Brigham and Women’s nurses rejected the hospital’s latest contract offer; their union says it wants to resume talks, but a strike remains possible. Primary Care Access: Australia’s share of GPs who bulk bill all patients more than doubled to 26%, but the RACGP warns some people still face higher out-of-pocket costs. Safer Treatment: A DNA test studied in about 6,000 prostate cancer patients may help doctors identify who could avoid more intensive treatment. Patient Safety: A South Korean doctor was fined after a patient died during acupuncture; the court found he failed to respond promptly to signs of distress.

Medication Adherence: A study of 91,339 people across nine trials found that missing blood-pressure medication can weaken its protection against heart attacks, strokes and other cardiovascular problems. Cancer Research: In a phase 3 trial of colorectal cancer that had spread to the liver, icosapent ethyl improved overall survival, with an estimated 32% lower risk of death at five years; the trial did not meet its primary endpoint of progression-free survival. Heart Care: Kuwait’s Adan Hospital has launched a minimally invasive catheter program to replace the tricuspid valve, performing its first two procedures through a small opening in the neck. Flu Season: Officials report flu hospitalizations are higher than usual for this time of year and are urging vaccination. Patient Care: Singapore’s KKH says virtual-reality sessions before surgery cut patients’ anxiety by about 30%, and are now offered to women scheduled for gynecological procedures.

Patient Privacy: Johns Hopkins Bayview is notifying about 3,182 patients after a staff member uploaded their information to an unapproved AI tool; the hospital says the data did not include Social Security or financial account numbers. Flu Season: Hospitalizations are running higher than usual, with the CDC reporting the rate is the highest for this point in the year since 2010. Cancer Care: In an interim trial, 76% of patients with a specific type of locally advanced rectal cancer had a complete response to dostarlimab, raising the possibility that some could avoid chemotherapy, radiation and surgery. Blood Supply: Namibia’s hospitals face rising demand for transfusions, while just 1.2% of the population donates blood annually; officials are urging more people to give. Health Information: Australian GPs say medical misinformation is becoming a bigger challenge, with 44% identifying it as a concern, up from 35% last year. Affordability: Reports of Medicare Advantage plan exits and possible Medicaid losses add to growing worries about access and rising health costs.

Ebola Response: The first participants have received an Ebola vaccine in a WHO-backed clinical trial in the Democratic Republic of the Congo, testing whether existing and experimental vaccines can protect against the outbreak strain. Clinical Research: AstraZeneca plans to invest $50 million in about 30 Abu Dhabi trials focused on cardiovascular, kidney and metabolic diseases, with the first expected to begin by year-end. Flu Season: U.S. flu hospitalizations are rising earlier than usual, reaching their highest rate for this point in the season since 2010, CDC data show. Medicare Coverage: Humana and UnitedHealthcare plan to end some Medicare Advantage plans next year, affecting about one million seniors; many will be offered other plans. Cancer Screening: Specialists warn that current lung cancer screening rules can miss nonsmokers, even though they account for up to one in five U.S. cases. Medicaid Access: A New Hampshire analysis estimates as many as 29,000 residents could lose coverage under new eligibility and reporting rules taking effect in January. Patient Safety: Federal authorities are directing states to crack down on hospitals reusing single-use medical devices.

Treatment Advance: A nonsurgical knee treatment eased osteoarthritis pain for 80% of patients in a study, offering a potential option for people seeking relief without surgery. Rising Costs: Patients are skipping doctor visits, rationing prescriptions and taking on debt as health costs climb; one woman described avoiding care because of a $10,000 deductible. Public Health: Kenya reported a second Ebola death, while Nigeria confirmed a case involving a Swiss diplomat’s wife who had returned from Uganda. Cancer Care: A reader worried that frequent scans for tiny pancreatic cysts were causing anxiety; doctors recommend monitoring because a mildly enlarged duct can raise cancer risk. Vaccine Policy: Florida is weighing removal of four vaccines from school-entry requirements, prompting doctors and hospitals to prepare for a possible rise in infectious disease. Medicare: Coverage changes are leaving some beneficiaries scrambling to find plans as open enrollment begins.

System Strain: Pakistan’s health minister warned the country’s healthcare system is nearing collapse as rapid population growth overwhelms limited resources. Nurse Staffing: B.C. Premier David Eby pledged to legislate minimum nurse-to-patient ratios if re-elected, with one nurse for every four patients the current standard in most care settings. Hospital Modernization: A €72.4 million program will upgrade 10 Moldovan hospitals, aiming to cut energy use by 40% and improve care for more than one million patients. Surgical Innovation: Bulgarian surgeons report a milestone remote robotic operation, with the surgeon operating from Shanghai while the patient was in Pleven. Cancer Care: New trial analyses found pancreatic cancer drug Rasonque improved survival across patient subgroups, including those without an identified RAS mutation. Public Health: Nigeria confirmed a Bundibugyo-strain Ebola case in a Swiss woman who had travelled to Uganda; 44 contacts were identified. In Chennai, daily medical camps have reached 27,150 people as officials prepare for monsoon-related health risks.

Infectious Disease: France reported the first documented human case of Shamonda virus in a severely immunocompromised patient, who died in early October. Investigations are ongoing. Cancer Research: A personalized mRNA vaccine added to standard treatment cut the risk of melanoma returning by 42% over two years in a major trial. Coverage Access: Santa Clara and Contra Costa counties are expanding local health programs as thousands face possible coverage losses; meanwhile, White River Health says it will leave UnitedHealthcare’s Medicare Advantage network in January, making open-enrollment choices especially important for patients. Hospital Pressures: A British hospital trust brought in mask rules early after respiratory infections among inpatients rose 80% in a week. Rural Nebraska hospitals also warn that new federal support may not offset financial strain. Healthcare Fraud: Federal officials charged 15 people, including medical professionals, in alleged schemes involving $2 billion in fraudulent claims.

Ebola Watch: Nigeria’s first Ebola patient in more than a decade is improving, the WHO says, but the agency says it was not told she had travelled to the Democratic Republic of Congo. Containment efforts are underway. Emerging Infection: France reported the first known human Shamonda virus infection; the patient died while seriously ill, and officials say there is no identified risk to the public as they investigate. Patient Access: More than 87,000 Iowa Medicare beneficiaries face plan cancellations or changes for 2027. Some will lose Medicare Advantage coverage at Mayo Clinic, making open-enrollment choices especially important. Hospital Safety: More than 100 pupils in Nigeria’s Ogun State were hospitalised after suspected gas exposure, prompting another school closure as authorities investigate the source. Care and Treatment: Studies highlight unequal access to antiamyloid drugs for people with mild cognitive impairment or dementia, while a chemotherapy-free combination showed promise for some older patients with lymphoma, with serious infections a key concern. Health Data: Quest Diagnostics is investigating unauthorized access to a system that may have exposed patient records.

Cancer Treatment: The FDA approved dostarlimab for some adults with stage 2 or 3 rectal cancer, offering eligible patients a chance to avoid chemotherapy, radiation and surgery. Medicare Changes: Blue Cross and Blue Shield of Texas will end its Medicare Advantage and prescription drug plans in 2027; affected members should review options during open enrollment, which ends Dec. 7. Medicaid Access: New rules are adding paperwork and eligibility checks for low-income Vermonters. Community benefit assisters are available free by calling 211. AI Safety: Researchers warn that harm from chatbots’ medical advice can go unreported because conversations are difficult for clinicians and regulators to access. FDA Oversight: A study found nearly 40% of reviewed advisory committee meetings included a patient or consumer representative with ties to drugmaker-funded groups, often undisclosed. Cancer Care: A new UK consensus calls for more consistent local and regional access to urgent and supportive oncology services.

Hospital Expansion: Sunway Healthcare and Putrajaya Holdings have formed a joint venture to develop a 325-bed specialist hospital, including a burns unit, in Malaysia’s Putrajaya. Clinical Findings: An early celiac-drug trial reported fewer symptoms and less gluten-related damage; a separate randomized study found noise-canceling headphones reduced post-surgery nausea, though results have not yet been peer-reviewed. Access to Care: An investigation in Armenia found a cancer patient paid out of pocket despite new insurance meant to cover part of her chemotherapy. In Iowa, a cancer center’s outreach clinic lets patients receive some follow-up closer to home. Patient Safety: The NFL Players Association is calling for a full investigation into the care Eagles quarterback Jalen Hurts received before doctors found blood clots in his lungs. Specialist Care: Selayang Hospital surgeons say they have successfully reattached both hands in three cases over 18 years; the latest patient is home and will return for rehabilitation.

Medicare Coverage: Open enrollment brings added uncertainty as insurers withdraw plans, including Blue Cross Blue Shield of Texas in 2027. Seniors are urged to check provider networks, drug coverage and costs before choosing. Hepatitis B Treatment: The FDA approved GSK’s Hibsago, a new option that may let some patients control the virus after stopping long-term treatment; trials found nearly one in five achieved undetectable virus levels and stayed off therapy for at least six months. ADHD Care: Nearly 300 trained GPs in New South Wales can now assess, diagnose and begin treating ADHD, potentially cutting waits and costs, especially for rural families. Cancer Services: Dana-Farber has begun building a $1.7 billion, 300-bed Boston cancer hospital, designed for intensive treatment and due to open in 2031. Hospital Capacity: UW Health’s $140 million East Madison expansion opens Nov. 2, adding operating rooms, beds and capacity for about 30% more surgeries. Autism Diagnosis: A five-year, $7 million NIH-backed study will train nearly 200 primary care clinicians to improve access to pediatric autism evaluations in underserved areas.

TB Treatment: Starting Nov. 1, PhilHealth will cover selected first-line medicines for eligible patients with drug-susceptible tuberculosis, without deducting the cost from their annual outpatient drug limit. Gene Therapy: A 43-year-old man in the UAE with transfusion-dependent thalassemia no longer needs regular transfusions after gene therapy, an encouraging result for a treatment that may offer a long-term option for some patients. Teen Health: A study of U.S. youth found girls ages 15–17 were more likely than boys to vape regularly in 2024: 7.8% versus 4.6%. Researchers urge pediatricians to watch for vaping, particularly among female patients. Medical Debt: About 8 million Americans ages 50–64 had medical debt in 2023, AARP estimates. Experts advise asking for costs before a procedure and checking whether a lower-cost care setting is an option. Myasthenia Gravis: The FDA approved a self-injector for Zilbrysq, but patients will have to wait until early 2027 for it to reach pharmacies.

Hospital Pressures: UK emergency doctors warn of a difficult winter: 92% report high or very high pressure, and only 3% say their department is well prepared. In Indore, medical teachers plan to suspend routine services Oct. 29–30 over unresolved demands, while emergency care is expected to continue. Affordable Medicines: India is cutting prices on 137 cancer drugs from Nov. 9. Tanzania plans to block insurance payments for medicines not registered with its regulator, aiming to protect patients from unsafe products. Cancer Care: Dana-Farber and Beth Israel are beginning construction of a $1.68 billion Boston cancer hospital, expected to open in 2031. A new NIH grant will also support a digital tool to monitor CAR-T patients’ side effects at home. Faster Emergency Care: Saudi Arabia’s King Faisal Specialist Hospital says an AI-supported patient-flow system and process changes cut median emergency-department boarding time by 75%, to 3.2 hours.

Rare-Disease Trial: Disc Medicine says its pill bitopertin met all primary and secondary goals in a late-stage trial for erythropoietic protoporphyria, which causes painful reactions to sunlight. The FDA had previously declined approval, citing uncertainty about whether lowering a blood marker improves patients’ sunlight tolerance. Dengue Surge: Bangladesh reported 1,851 new cases and four deaths in 24 hours, bringing this year’s toll to 352 deaths and more than 114,000 cases. Hospital Capacity: A newly expanded 75-bed emergency department opened at Quezon Medical Center in the Philippines, while London’s Queen’s Hospital secured £42 million to overhaul an A&E department handling more than twice its original daily patient load. Staffing and Safety: Philippine President Ferdinand Marcos Jr. pledged to improve nurse-to-patient ratios and fill vacant posts. At Accra’s Ridge Hospital, simulation training is preparing doctors and midwives to manage obstetric emergencies. Winter Outlook: U.S. hospitals should prepare for a respiratory-virus peak similar to last season’s, the CDC says, as flu activity begins rising earlier than usual.